According to former employees, telehealth company LifeMD, which works closely with GLP-1 manufacturer Novo Nordisk, is overprescribing weight-loss drugs with little to no oversight, risking patient safety.
Here & Now‘s Scott Tong speaks with Elaine Chen, reporter for STAT.
This article was originally published on WBUR.org.
Copyright 2026 WBUR
